These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 22907238)

  • 41. Botulinum toxin type A for upper limb spasticity after stroke.
    Shaw L; Rodgers H
    Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of switching therapy from complexing protein-containing botulinum toxin type A to a formulation with low immunogenicity in spasticity after stroke: a case report.
    Santamato A; Ranieri M; Panza F; Frisardi V; Micello MF; Filoni S; Fiore P
    J Rehabil Med; 2012 Sep; 44(9):795-7. PubMed ID: 22915045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G
    Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke.
    Gordon MF; Brashear A; Elovic E; Kassicieh D; Marciniak C; Liu J; Turkel C;
    Neurology; 2004 Nov; 63(10):1971-3. PubMed ID: 15557529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of NT 201 for upper limb spasticity of various etiologies--a randomized parallel-group study.
    Barnes M; Schnitzler A; Medeiros L; Aguilar M; Lehnert-Batar A; Minnasch P
    Acta Neurol Scand; 2010 Oct; 122(4):295-302. PubMed ID: 20456248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Managing upper extremity clonus with intramuscular botulinum toxin-A injections in a patient poststroke.
    Kassam A; Phadke CP; Ismail F; Boulias C
    PM R; 2015 May; 7(5):542-6. PubMed ID: 25459654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
    Simpson DM; Gracies JM; Graham K; Hallett M; Miyasaki J; Naumann M; Russman B; Simpson L; So Y
    Neurology; 2009 Sep; 73(9):736-7; author reply 737-8. PubMed ID: 19728407
    [No Abstract]   [Full Text] [Related]  

  • 48. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials.
    Jia S; Liu Y; Shen L; Liang X; Xu X; Wei Y
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104682. PubMed ID: 32305277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
    Seo HG; Paik NJ; Lee SU; Oh BM; Chun MH; Kwon BS; Bang MS
    PLoS One; 2015; 10(6):e0128633. PubMed ID: 26030192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
    J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relapsing-remitting severe generalized muscular weakness after botulinum toxin treatment for hyperhidrosis.
    Chiarello D; Piombo M; Corbetto M; Di Pino G; Assenza G; Capone F; Di Lazzaro V
    Muscle Nerve; 2014 Sep; 50(3):456-7. PubMed ID: 24890202
    [No Abstract]   [Full Text] [Related]  

  • 53. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
    Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
    Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity.
    Kaku M; Simpson DM
    Drug Des Devel Ther; 2016; 10():1085-99. PubMed ID: 27022247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Botulinum toxin type A injection, followed by home-based functional training for upper limb hemiparesis after stroke.
    Takekawa T; Kakuda W; Taguchi K; Ishikawa A; Sase Y; Abo M
    Int J Rehabil Res; 2012 Jun; 35(2):146-52. PubMed ID: 22453625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of a 15-years' experience in including shoulder muscles, when treating upper-limb spasticity post-stroke with botulinum toxin type A.
    Carvalho MP; Pinto D; Gorayeb M; Jacinto J
    Top Stroke Rehabil; 2018 Apr; 25(3):194-202. PubMed ID: 29322885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
    Bakheit AM; Thilmann AF; Ward AB; Poewe W; Wissel J; Muller J; Benecke R; Collin C; Muller F; Ward CD; Neumann C
    Stroke; 2000 Oct; 31(10):2402-6. PubMed ID: 11022071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.
    Zeuner KE; Knutzen A; Kühl C; Möller B; Hellriegel H; Margraf NG; Deuschl G; Stolze H
    Brain Inj; 2017; 31(1):75-82. PubMed ID: 27880052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of botulinum toxin treatment for spasticity and bleeding complications in patients with thrombotic risk.
    Phadke CP; Thanikachalam V; Ismail F; Boulias C
    Toxicon; 2017 Nov; 138():188-190. PubMed ID: 28919457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics].
    Yelnik AP
    Ann Readapt Med Phys; 2004 Oct; 47(8):575-89. PubMed ID: 15465163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.